PRESERVED EJECTION FRACTION
Clinical trials for PRESERVED EJECTION FRACTION explained in plain language.
Never miss a new study
Get alerted when new PRESERVED EJECTION FRACTION trials appear
Sign up with your email to follow new studies for PRESERVED EJECTION FRACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a smarter pacemaker lead protect the heart?
Disease control Not yet recruitingThis trial tests whether a newer pacing method, called left bundle branch area pacing, is better than the standard right ventricular pacing for adults with permanent atrial fibrillation and a need for a pacemaker. The goal is to see if the newer technique reduces the risk of deat…
Matched conditions: PRESERVED EJECTION FRACTION
Phase: NA • Sponsor: Poitiers University Hospital • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New study eyes Tirzepatide's hidden impact on joints and heart
Knowledge-focused Not yet recruitingThis observational study in Mexico will follow 30 adults already taking tirzepatide for conditions like diabetes or obesity. Researchers will use MRI scans of the knees, CT scans of the heart, and body composition tests to see how the drug affects cartilage, heart fat, and overal…
Matched conditions: PRESERVED EJECTION FRACTION
Sponsor: JULIO GRANADOS MONTIEL • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Jardiance under the microscope: new study tracks heart failure outcomes in china
Knowledge-focused Not yet recruitingThis study will observe 3,000 adults in China with a type of heart failure called HFpEF who are starting the drug Jardiance. Researchers will track how many patients are hospitalized for heart failure or die from heart-related causes over time. The goal is to see how effective an…
Matched conditions: PRESERVED EJECTION FRACTION
Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC